These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5017117)

  • 1. Evaluation of a sustained-release preparation containing d-isoephedrine sulphate using a urinary excretion technique.
    Lötter AP; Van Oudtshoorn MC
    S Afr Med J; 1972 Feb; 46(9):226-8. PubMed ID: 5017117
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary excretion of ephedrine in man without pH control following oral administration of three commercial ephedrine sulfate preparations.
    Welling PG; Lee KP; Patel JA; Walker JE; Wagner JG
    J Pharm Sci; 1971 Nov; 60(11):1629-34. PubMed ID: 5133909
    [No Abstract]   [Full Text] [Related]  

  • 3. Sustained release theophylline and ephedrine therapy in chronic asthma.
    Direkwattanachai C; Phanichyakarn P; Srianujatra S
    J Med Assoc Thai; 1986 Oct; 69 Suppl 2():31-7. PubMed ID: 3805945
    [No Abstract]   [Full Text] [Related]  

  • 4. The metabolism of (+-)-methylephedrine in rat and man.
    Inoue T; Suzuki S
    Xenobiotica; 1990 Jan; 20(1):99-106. PubMed ID: 2327112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation of sustained release tablets containing norephedrine chloride.
    Lindberg NO; Persson CG
    Acta Pharm Suec; 1972 Jun; 9(3):237-48. PubMed ID: 5053673
    [No Abstract]   [Full Text] [Related]  

  • 6. The relevance of the urinary concentration of ephedrines in anti-doping analysis: determination of pseudoephedrine, cathine, and ephedrine after administration of over-the-counter medicaments.
    Strano-Rossi S; Leone D; de la Torre X; Botrè F
    Ther Drug Monit; 2009 Aug; 31(4):520-6. PubMed ID: 19571776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotransformation of D(-)-ephedrine and L(+)-ephedrine in the rabbit, in vivo and in vitro.
    Feller DR; Malspeis L
    Drug Metab Dispos; 1977; 5(1):37-46. PubMed ID: 13974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption metabolism and excretion of the ephedrines in man. I. The influence of urinary pH and urine volume output.
    Wilkinson GR; Beckett AH
    J Pharmacol Exp Ther; 1968 Jul; 162(1):139-47. PubMed ID: 5656593
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on the analysis of drugs by use of radioisotopes. VII. Identification of metabolites of ephedrine in rabbit].
    Matsuda A; Baba S; Nagase Y
    Yakugaku Zasshi; 1971 May; 91(5):542-5. PubMed ID: 5105139
    [No Abstract]   [Full Text] [Related]  

  • 10. Spaneph: slow-release ephedrine.
    Drug Ther Bull; 1970 Apr; 8(8):31. PubMed ID: 5431606
    [No Abstract]   [Full Text] [Related]  

  • 11. [Correlation between dissolution in vitro and absorption in vivo of chuanping sustained release tablets].
    Cai YQ; Zhang ZP; Wu YH; Liu J; Xie JF; Chai JZ; Luo Y; Zhu SS
    Zhongguo Zhong Yao Za Zhi; 2013 Oct; 38(20):3473-8. PubMed ID: 24490556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of ephedrine after nasal application in healthy volunteers.
    Lefebvre RA; Surmont F; Bouckaert J; Moerman E
    J Pharm Pharmacol; 1992 Aug; 44(8):672-5. PubMed ID: 1359093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability assessment of a new liquid controlled-release pseudoephedrine product.
    Graves DA; Rotenberg KS; Woodworth JR; Amsel LP; Hinsvark ON
    Clin Pharm; 1985; 4(2):199-203. PubMed ID: 3987221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption, metabolism, and excretion of the ephedrines in man. II. Pharmacokinetics.
    Wilkinson GR; Beckett AH
    J Pharm Sci; 1968 Nov; 57(11):1933-8. PubMed ID: 5725924
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biopharmaceutic investigations with D-norpseudoephedrine. 2nd communication: Bioavaliability of a depot preparation (author's transl)].
    Frosch F
    Arzneimittelforschung; 1977; 27(5):1076-8. PubMed ID: 577875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of Tardyferon-depot dragées].
    Largiadèr A
    Schweiz Rundsch Med Prax; 1973 May; 62(18):578-82. PubMed ID: 4575824
    [No Abstract]   [Full Text] [Related]  

  • 17. Slow release salbutamol and Tedral in the treatment of reversible airways obstruction.
    Lal S; Bhalla KK; Davey AJ
    Postgrad Med J; 1971 Mar; 47():Suppl:89-92. PubMed ID: 4929401
    [No Abstract]   [Full Text] [Related]  

  • 18. Spaneph: data on efficiency.
    Drug Ther Bull; 1970 Oct; 8(21):83. PubMed ID: 5491287
    [No Abstract]   [Full Text] [Related]  

  • 19. [Influence of desipramine treatment on metabolism of ephedrine-C 14 in the rat].
    Jacquot C; Bralet J; Cohen Y; Valette G
    C R Seances Soc Biol Fil; 1970; 164(1):86-92. PubMed ID: 4248051
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of asthma with a new prolonged-action drug].
    Dubois de Montreynaud JM
    Therapeutique; 1971 Mar; 47(3):249-52. PubMed ID: 5557327
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.